Corvidia Therapeutics Employee Directory

Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees

Corvidia Therapeutics is a biotechnology company focused on precision therapies that emerge from studying how random genetic variation reshapes networks governing protein function and disease in different patients. By mapping these genomic networks, the company aims to anticipate how a personalized treatment for complex diseases may behave in distinct patient groups before clinical trials. Based in Waltham, Massachusetts, the organization describes itself as a small team of scientists and drug developers pursuing approaches to tailor therapies across a range of diseases.

Its work sits at the intersection of genomics and pharmaceutical development, providing a framework that informs drug design and patient stratification beyond traditional methods. The company targets collaborations with pharmaceutical developers seeking therapies for complex diseases where patient-specific genomic context could influence outcomes. In 2020, Novo Nordisk acquired Corvidia Therapeutics, reflecting a transition of the company within a larger corporate context.

Sign up for free to view info

Company overview Email format